SCHEMBL6207592

SCHEMBL6207592

O=C1NCN=c2cc3c(cc21)=CC=N3

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7216532 0.66 CYP19A1 (0.35)
SCHEMBL7962744 0.64
SCHEMBL4143118 0.60
SCHEMBL4078808 0.60
SCHEMBL5619234 0.58
SCHEMBL31537953 0.54
SCHEMBL8776640 0.51
SCHEMBL8723997 0.51
SCHEMBL1720840 0.49
SCHEMBL13210386 0.47

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0907642-B1 PHENYLAMINO-SUBSTITUTED TRICYCLIC DERIVATIVES FOR TREATMENT OF HYPERPROLIFERATIVE DISEASES PFIZER (US) 2005-11-02 EP disclosed
US-6335344-B1 Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases PFIZER INC. 2002-01-01 US disclosed